Rep. Frank Pallone, Jr. (D-NJ) and Sen. Dick Durbin (D-IL) are seeking to prohibit tianeptine, also known as “gas station heroin”, from being marketed to consumers with companion bills in both chambers of the U.S. Congress.
In a letter addressed to U.S. Senator Richard Durbin (D-IL) dated March 26, 2024, the National Products Association (NPA) reiterated its continued objection to the re-introduction of the Dietary Supplement Listing Act.
In this guest column, the Natural Products Association's Dr. Daniel Fabricant outlines his organization's opposition to FDA's proposal for a mandatory product listing for all dietary supplements.
The U.S. Food and Drug Administration has outlined its budget and legislative proposals for 2025, with the only dedicated section concerning dietary supplements renewing calls for mandatory product listing and seeking clarifications on the Agency's authorities.
The National Institutes of Health kicked off its annual Office of Dietary Supplements Seminar Series this week with a presentation by Dr. Cara Welch on how the Food and Drug Administration (FDA) regulates the dietary supplement marketplace.